These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38521374)

  • 1. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy.
    Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W
    Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
    Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
    Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
    Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
    Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
    J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
    Rao Z; Xia Y; Jia Q; Zhu Y; Wang L; Liu G; Liu X; Yang P; Ning P; Zhang R; Zhang X; Qiao C; Wang Z
    J Nanobiotechnology; 2023 Aug; 21(1):265. PubMed ID: 37563614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
    Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
    Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy.
    Liang Y; Zhang L; Peng C; Zhang S; Chen S; Qian X; Luo W; Dan Q; Ren Y; Li Y; Zhao B
    Acta Pharm Sin B; 2021 Oct; 11(10):3231-3243. PubMed ID: 34729312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
    Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
    Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
    Wan X; Song L; Pan W; Zhong H; Li N; Tang B
    ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zwitterionic polymer coated sorafenib-loaded Fe
    Lin J; Zhang J; Wang K; Guo S; Yang W
    J Mater Chem B; 2022 Aug; 10(30):5784-5795. PubMed ID: 35861050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy.
    He H; Du L; Guo H; An Y; Lu L; Chen Y; Wang Y; Zhong H; Shen J; Wu J; Shuai X
    Small; 2020 Aug; 16(33):e2001251. PubMed ID: 32677157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel Lipid Peroxide Accumulation Strategy Based on Bimetal-Organic Frameworks for Enhanced Ferrotherapy.
    Xin H; Wang F; Luo R; Lei J
    Chemistry; 2021 Mar; 27(13):4307-4311. PubMed ID: 33377225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
    Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
    Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
    He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
    Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
    Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
    Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
    Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
    Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
    Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
    J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable and Efficient Charge-Migrated Z-Scheme Heterojunction Amplifies Cancer Ferroptosis by Blocking Defensive Redox System.
    Liu Y; Yi Y; Sun S; Wang T; Tang J; Peng Z; Huang W; Zeng W; Wu M
    Small; 2024 Jun; 20(23):e2309206. PubMed ID: 38149505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
    Liu X; Zhu X; Qi X; Meng X; Xu K
    Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.